Insight Molecular Diagnostics (IMDX) EBITDA Margin (2020 - 2026)
Insight Molecular Diagnostics (IMDX) recorded EBITDA Margin of -4492.47% in Q2 2026, down 2700.38 percentage points from -1792.08% a year earlier but up 7326.28 percentage points from the prior quarter.
Insight Molecular Diagnostics (IMDX) EBITDA Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Insight Molecular Diagnostics' EBITDA Margin came in at -2864.97% as of Jun 30, 2026, down 1414.77 percentage points year-over-year; for FY2025, it came in at -1206.34%, up 1950.97 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +1204.60 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -3157.31% in FY2024 (-1597.23 pp), -1560.08% in FY2023 (-223.44 pp), -1336.64% in FY2022 (+918.32 pp) and -2254.96% in FY2021 (+155.98 pp).
- Quarterly EBITDA Margin has ranged from -11818.75% in Q1 2026 to 2128.62% in Q1 2023 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of -832.35 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 7431.91 percentage points in Q3 2025, against a drop of 11524.04 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -11818.75% (Q1 2026), -2007.20% (Q4 2025) and -4024.62% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 24.62% |
| 10 | Insight Molecular Diagnostics | 117.12 Mn | 40.83 Mn | 157,000.00 | -4,492.47% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,492.47% |
| Mar 31, 2026 | -11,818.75% |
| Dec 31, 2025 | -2,007.20% |
| Sep 30, 2025 | -4,024.62% |
| Jun 30, 2025 | -1,792.08% |
| Mar 31, 2025 | -294.71% |
| Dec 31, 2024 | -2,219.11% |
| Sep 30, 2024 | -11,456.52% |
| Jun 30, 2024 | -4,140.38% |
| Mar 31, 2024 | -5,075.00% |
| Dec 31, 2023 | -5,050.00% |
| Sep 30, 2023 | -1,418.88% |
| Jun 30, 2023 | -1,692.66% |
| Mar 31, 2023 | 2,128.62% |
| Dec 31, 2022 | -3,816.06% |
| Sep 30, 2022 | -505.97% |
| Jun 30, 2022 | -112.24% |
| Mar 31, 2022 | -474.21% |
| Dec 31, 2021 | -960.49% |
| Sep 30, 2021 | -1,256.00% |
Insight Molecular Diagnostics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();